Industrial Investors Group

Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics. Its Amphivena ReSTORE platform provides dual-action biologics that relieve immune suppression and activate T cell effector function in cancer patients. The platform design integrates elements of avidity, target selectivity, and enhanced safety within a single molecule. It is also can be engineered with additional solid tumor targeting modalities to add functionality such as directed tumor cell killing. It was founded in 2012 and is headquartered in South San Francisco, California.

Bojangles, Inc. operates and franchises limited-service restaurants across the United States, specializing in Southern cuisine. Founded in 1977 and headquartered in Charlotte, North Carolina, the company offers a diverse menu that includes made-to-order chicken, biscuits, family meals, sandwiches, salads, and various beverages. Notable items include their signature buttermilk biscuits, hand-breaded bone-in fried chicken, and a range of sides often referred to as "fixin's." Bojangles aims to provide high-quality food and friendly service, appealing to customers with its distinctive flavors and casual dining experience.

Low-cost, self-powered ocean surface drones, deployed in fleets that form an intelligent sensor network to collect and transmit marine data

ARMO BioSciences, Inc. is an immuno-oncology company based in Redwood City, California, focused on developing biologic therapeutics that stimulate the immune system to combat cancer. The company's product pipeline includes several innovative candidates, such as AM0010, a long-acting form of interleukin-10 that enhances immune response, and AM0001, an anti-PD-1 monoclonal antibody targeting various cancers. Other key products in development include an anti-LAG-3 checkpoint inhibitor, AM0015, a recombinant form of interleukin-15, and AM0012, a recombinant interleukin-12. Established in 2010 and formerly known as Targenics, ARMO BioSciences aims to activate and enhance the body's immune response against tumors, thereby improving outcomes for cancer patients. As of mid-2018, it operates as a subsidiary of Eli Lilly and Company.

Crocus Technology SA specializes in magnetic random access memory products and technologies tailored for the semiconductor and electronic systems industries. The company develops magnetic sensors and embedded memory technology that facilitate efficient sensor data gathering and processing. Its products are designed for diverse applications, including telecommunications, networking, storage, computing, and handheld devices. Crocus Technology's innovative solutions enable fast read and write operations while maintaining a compact footprint, which enhances chip performance and security for devices such as smart cards, mobile phones, and data servers. By focusing on high sensitivity, stable temperature performance, and low power consumption, the company aims to improve productivity for its clients across various sectors.

Crocus Technology SA specializes in magnetic random access memory products and technologies tailored for the semiconductor and electronic systems industries. The company develops magnetic sensors and embedded memory technology that facilitate efficient sensor data gathering and processing. Its products are designed for diverse applications, including telecommunications, networking, storage, computing, and handheld devices. Crocus Technology's innovative solutions enable fast read and write operations while maintaining a compact footprint, which enhances chip performance and security for devices such as smart cards, mobile phones, and data servers. By focusing on high sensitivity, stable temperature performance, and low power consumption, the company aims to improve productivity for its clients across various sectors.

Transas offers best-in-class navigation systems and integrated bridge solutions